Author(s):
1. Asif Husain Osmani:
Department of Oncology, King Faisal Specialist Hospital and Research Centre,Riyadh, Saudia Arabia,
2. Irfan Maghfoor:
Department of Oncology, King Faisal Specialist Hospital and Research Centre,Riyadh, Saudia Arabia,
Abstract:
Cardiac lymphomas, either primary or secondary, are mostly of B-cell lineage; among which, di use large B-cell lymphoma (DLBCL) is the most common. Secondary involvement of the heart is usually a late manifestation of disseminated lymphoma. Patients may be asymptomatic or may have non-speci c symptoms, particularly when cardiac involvement is not extensiveA. 22-year male patient presented with four months history of progressive enlargement of left cervical lymph nodes with intermittent fever along with dysphagia and left ear pain. Positron-emission tomography (PET)/computed tomography (CT) scan revealed abnormal uorodeoxyglucose (FDG) uptake in multiple systemic locations including inferior wall of the myocardium. Subsequently, cardiac MRI showed left ventricular posterolateral wall abnormal area of delayed enhancement, corresponding to the FDG uptake on PET CT scan. Patient had remission after completion of standard chemotherapy protocol for the management of DLBCL with acceptable toxicity.
Page(s):
1102-1104
Published:
Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 9, Year: 2021
Keywords:
Heart
,
chemotherapy
,
Secondary
,
Di use large Bcell lymphoma DLBCL
References:
References are not available for this document.
Citations
Citations are not available for this document.